S&P 500   3,096.42 (+0.15%)
DOW   27,766.24 (+0.27%)
QQQ   201.65 (+0.05%)
CGC   18.77 (-2.49%)
BABA   182.56 (-2.36%)
GE   11.33 (-0.79%)
T   39.18 (+0.00%)
F   8.89 (-1.66%)
ACB   3.51 (-1.68%)
BAC   32.86 (-0.70%)
DIS   144.90 (+4.56%)
S&P 500   3,096.42 (+0.15%)
DOW   27,766.24 (+0.27%)
QQQ   201.65 (+0.05%)
CGC   18.77 (-2.49%)
BABA   182.56 (-2.36%)
GE   11.33 (-0.79%)
T   39.18 (+0.00%)
F   8.89 (-1.66%)
ACB   3.51 (-1.68%)
BAC   32.86 (-0.70%)
DIS   144.90 (+4.56%)
S&P 500   3,096.42 (+0.15%)
DOW   27,766.24 (+0.27%)
QQQ   201.65 (+0.05%)
CGC   18.77 (-2.49%)
BABA   182.56 (-2.36%)
GE   11.33 (-0.79%)
T   39.18 (+0.00%)
F   8.89 (-1.66%)
ACB   3.51 (-1.68%)
BAC   32.86 (-0.70%)
DIS   144.90 (+4.56%)
S&P 500   3,096.42 (+0.15%)
DOW   27,766.24 (+0.27%)
QQQ   201.65 (+0.05%)
CGC   18.77 (-2.49%)
BABA   182.56 (-2.36%)
GE   11.33 (-0.79%)
T   39.18 (+0.00%)
F   8.89 (-1.66%)
ACB   3.51 (-1.68%)
BAC   32.86 (-0.70%)
DIS   144.90 (+4.56%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 TocagenNovelion TherapeuticsRegulus TherapeuticsCellectar BiosciencesKITOV PHARMA LT/S
SymbolNASDAQ:TOCANASDAQ:NVLNNASDAQ:RGLSNASDAQ:CLRBNASDAQ:KTOV
Price Information
Current Price$0.62$0.68$0.65$1.08$0.71
52 Week RangeHoldHoldHoldBuyBuy
Analyst Ratings
Consensus RecommendationHoldHoldHoldBuyBuy
Consensus Price Target$11.42N/A$1.50$6.67N/A
% Upside from Price Target1,741.13% upsideN/A130.77% upside517.28% upsideN/A
Trade Information
Market Cap$15.16 million$13.34 million$14.37 million$12.87 million$13.83 million
Beta3.892.121.461.253.59
Average Volume410,014200,344189,629231,397838,387
Sales & Book Value
Annual Revenue$18.04 million$130.43 million$70,000.00N/A$1 million
Price / Sales0.820.10193.38N/A13.87
CashflowN/AN/AN/AN/A$0.36 per share
Price / CashN/AN/AN/AN/A2.00
Book Value$2.91 per share($4.69) per share($0.67) per share$2.26 per share$0.70 per share
Price / Book0.21-0.14-0.97N/A1.01
Profitability
Net Income$-48,960,000.00$-108,330,000.00$-48,710,000.00$-13,240,000.00$-5,200,000.00
EPS($2.44)N/A($5.59)($4.66)$0.39
Trailing P/E RatioN/A0.00N/AN/A1.82
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-300.42%-79.43%-396.84%N/AN/A
Return on Equity (ROE)-115.81%N/A-179,717.33%-135.68%N/A
Return on Assets (ROA)-58.04%-26.13%-100.18%-96.21%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.86%N/AN/A0.03%0.01%
Current Ratio4.21%0.24%1.19%6.80%1.99%
Quick Ratio4.21%0.21%1.19%6.80%N/A
Ownership Information
Institutional Ownership Percentage35.20%35.00%45.01%21.29%0.39%
Insider Ownership Percentage10.90%3.60%10.70%4.26%2.98%
Miscellaneous
Employees7710924710
Shares Outstanding23.90 million19.62 million20.83 million9.40 million19.53 million
Next Earnings Date2/26/2020 (Estimated)N/A3/16/2020 (Estimated)N/AN/A
OptionableOptionableOptionableOptionableNot OptionableNot Optionable
 TocagenNovelion TherapeuticsRegulus TherapeuticsCellectar BiosciencesKITOV PHARMA LT/S

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel